Tutti i video
Autoantibody screening for prevention of type 1 diabetes
it
Prof. Emanuele Bosi
Why use CGMs in type 2 diabetes also
en
Prof. Satish Garg
Efficacia dell'Irisina contro il diabete: i nostri brevetti in USA e in EU
it
Prof. Francesco Giorgino
Tissue Engineering and Cellular Replacement in Diabetes Treatment
en
Prof. Camillo Ricordi
Q & A: a clinical case of unstable diabetes, integrated sensor and insuline infusion sets
it
Guidelines on the presymptomatic phase of type 1 diabetes
it
Prof. Emanuele Bosi
How to prevent or delay the onset of type 2 diabetes from prediabetes
en
Prof. Satish Garg
Irisina: dalla scoperta delle proprietà alla formulazione del farmaco
it
Prof. Francesco Giorgino
Ingegneria tissutale e ricambio cellulare nel trattamento del diabete
it
Prof. Camillo Ricordi
Q & A: does the Free Style Libre system have any faults?
it
Effective self-monitoring of glycaemia: why this procedure is indispensable
it
Prof. Salvatore Caputo
The resistance to change in diabetes management
en
Prof. Satish Garg
Role of GLP analogues in people with type 1 diabetes
en
Prof. Satish Garg
Procedure e tempi per l'approvazione Tutte le proprietà dell'Irisina
it
Prof. Francesco Giorgino
Is Type 1 Diabetes Mellitus an Autoimmune Disease?
en
Prof. Mark Sperling
Q & A: subcutaneous and blood glucose measurements – what are the differences?
it
Video presentation of the Free Style Libre system
it
The hot topics discussed at ATTD 2023
en
Prof. Satish Garg
The Evolution of Glycemic Targets: Time in Tight Range
en
Prof. Viral N. Shah
L'Irisina per rafforzare il trapianto di isole pancreatiche
it
Prof. Francesco Giorgino
Big data open a new era in diabetes management
en
Dr. Thomas Danne
How does the new method work. Cost-benefit ratio
it
Prof. Emanuele Bosi
Q & A: diabetes, technology changes the doctor/patient relation
it
Q & A: teaching about the application and use of the sensor
it
Determining glycaemic variability: the role of AGP
it
Dott. Stefano Genovese
Q & A: lipodistrophy, allarms, device life-time, online purchase
it
Clinical case: Claudio Pellizzeni’s AGP analyses
it
Dott. Stefano Genovese
Claudio Pelizzeni’s report on his glycaemic profile during his trip around the world
it
Glucose monitoring: from the glucose meter to the Free St. Libre system
it
Prof. Salvatore Caputo
Reimbursement policies for Continuous Glucose Monitoring
en
Prof. Lutz Heinemann
Type 1 diabetes variabilities are easier to manage with AGP
it
Prof. Emanuele Bosi
Advanced technologies in type 1 diabetes: what is the cost/benefit ratio?
it
Prof. Emanuele Bosi
Diabete 1: trapianto di cellule beta da staminali, il trial clinico in corso
it
Dr. Francesca D’Addio
Patient compliance and application range of the new system
it
Dott. Stefano Genovese